Cognitive inhibition impairments in presymptomatic


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
04 2020
Historique:
received: 17 10 2019
revised: 13 01 2020
accepted: 15 01 2020
pubmed: 15 2 2020
medline: 18 8 2020
entrez: 15 2 2020
Statut: ppublish

Résumé

To investigate cognitive inhibition in presymptomatic Thirty-eight presymptomatic C9+ individuals younger than 40 years had higher error scores (part B) but equivalent HSCT time to completion (part B-part A) compared to C9- individuals. C9+ individuals older than 40 years had both higher error scores and longer time to completion. HSCT time to completion significantly predicted the proximity to estimated clinical conversion from presymptomatic to symptomatic phase in C9+ individuals (based on the average age at onset of affected relatives in the family). Anatomically, we found that HSCT time to completion was associated with the integrity of the cerebellum. The HSCT represents a good marker of cognitive inhibition impairments in C9+ and of proximity to clinical conversion. This study also highlights the key role of the cerebellum in cognitive inhibition.

Identifiants

pubmed: 32054668
pii: jnnp-2019-322242
doi: 10.1136/jnnp-2019-322242
doi:

Substances chimiques

C9orf72 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-372

Subventions

Organisme : CIHR
Pays : Canada

Investigateurs

Carole Aubier Girard (CA)
Eve Benchetrit (E)
Hugo Bertin (H)
Anne Bertrand (A)
Sandrine Bioux (S)
Anne Bissery (A)
Évangéline Bliaux (É)
Stéphanie Bombois (S)
Marie-Paule Boncoeur (MP)
Pascaline Cassagnaud (P)
Mathieu Chastan (M)
Yaohua Chen (Y)
Marie Chupin (M)
Olivier Colliot (O)
Philippe Couratier (P)
Xavier Delbeuck (X)
Vincent Deramecourt (V)
Christine Delmaire (C)
Emmanuel Gerardin (E)
Claude Hossein-Foucher (C)
Bruno Dubois (B)
Marie-Odile Habert (MO)
Didier Hannequin (D)
Géraldine Lautrette (G)
Thibaud Lebouvier (T)
Isabelle Le Ber (IL)
Stéphane Lehéricy (S)
Benjamin Le Toullec (BL)
Richard Levy (R)
Olivier Martinaud (O)
Kelly Martineau (K)
Marie-Anne Mackowiak (MA)
Jacques Monteil (J)
Florence Pasquier (F)
Grégory Petyt (G)
Pierre-François Pradat (PF)
Dorothée Pouliquen (D)
Assi-Hervé Oya (AH)
Daisy Rinaldi (D)
Adeline Rollin-Sillaire (A)
François Salachas (F)
Sabrina Sayah (S)
David Wallon (D)

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Maxime Montembeault (M)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris, France.
FrontLab, Paris, France.
Department of Neurology, University of California San Francisco, Memory and Aging Center, San Francisco, California, USA.

Sabrina Sayah (S)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.

Daisy Rinaldi (D)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Benjamin Le Toullec (B)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Anne Bertrand (A)

Sorbonne University, Paris, France.
Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Institut du Cerveau et la Moelle Épinière, FrontLAB, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Aramis Project Team, Inria Research Center of Paris, Paris, France.

Aurélie Funkiewiez (A)

Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Institute of Memory and Alzheimer's Disease, Centre of Excellence of Neurodegenerative Disease, Department of Neurology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Dario Saracino (D)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Aramis Project Team, Inria Research Center of Paris, Paris, France.

Agnès Camuzat (A)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.

Philippe Couratier (P)

Centre de Référence SLA et autres maladies du motoneurone, Centre Hospitalier Universitaire de Limoges, Limoges, France.
Centre de Compétence Démences Rares, Centre Hospitalier Universitaire de Limoges, Limoges, France.

Marianne Chouly (M)

Centre de Référence SLA et autres maladies du motoneurone, Centre Hospitalier Universitaire de Limoges, Limoges, France.
Centre de Compétence Démences Rares, Centre Hospitalier Universitaire de Limoges, Limoges, France.

Didier Hannequin (D)

Centre National de Référence pour les Malades Alzheimer Jeunes, Centre Hospitalier Universitaire de Rouen, INSERM 1245, Rouen, France.
Department of Neurology, Centre Hospitalier Universitaire de Rouen, Rouen, France.

Carole Aubier-Girard (C)

Centre National de Référence pour les Malades Alzheimer Jeunes, Centre Hospitalier Universitaire de Rouen, INSERM 1245, Rouen, France.
Department of Neurology, Centre Hospitalier Universitaire de Rouen, Rouen, France.

Florence Pasquier (F)

Université de Lille, INSERM U1171, Centre de la mémoire (CMRR), Centre national de référence pour les malades Alzheimer jeunes (CNRMAJ), CHU Lille, Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease (DistAlz), Lille, France.

Xavier Delbeuck (X)

Université de Lille, INSERM U1171, Centre de la mémoire (CMRR), Centre national de référence pour les malades Alzheimer jeunes (CNRMAJ), CHU Lille, Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease (DistAlz), Lille, France.

Olivier Colliot (O)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Aramis Project Team, Inria Research Center of Paris, Paris, France.

Bénédicte Batrancourt (B)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris, France.
FrontLab, Paris, France.

Carole Azuar (C)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
FrontLab, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Richard Lévy (R)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris, France.
FrontLab, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Bruno Dubois (B)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Isabelle Le Ber (I)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France.
Sorbonne University, Paris, France.
FrontLab, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Raffaella Migliaccio (R)

Inserm U1127, Institut du Cerveau, Hôpital Pitié-Salpêtrière, Paris, France lara.migliaccio@gmail.com.
Sorbonne University, Paris, France.
FrontLab, Paris, France.
Reference Centre for Rare of Early Onset Dementias, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH